Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IGF-1 in ALS
NCT00035815Phase 3Completed
- Sponsor
- Mayo Clinic
- Start
- Jun 2003
- Primary completion
- Aug 2007
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 2
01
Overview
A Phase 3 trial of mecasermin in amyotrophic lateral sclerosis (ALS), sponsored by Mayo Clinic. Started Jun 2003; status: completed.
02
Drugs
mecasermin
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT00035815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00035815.